Sandu Pharmaceuticals, Inc. (SANDUPHQ)
Market Closed
11 Aug, 22:00
MSE MSE Primary ₹
39. 48
-0.32
-0.804%
₹
328.47M Market Cap
98.21 P/E Ratio
1.6% Div Yield
721 Volume
0 Eps
₹ 39.8
Previous Close Want to track SANDUPHQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
SANDUPHQ closed today lower at ₹39.48, a decrease of -0.804% from yesterday's close, completing a monthly decrease of -3.7073% or -₹1.52. Over the past 12 months, SANDUPHQ stock gained 4.1689%.
SANDUPHQ pays dividends to its shareholders, with the most recent payment made on Oct 30, 2025. The next estimated payment will be in In 2 months on Oct 30, 2026 for a total of ₹0.8.
The last earnings report, released on May 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.5173%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
SANDUPHQ Chart
People also search for
Sandu Pharmaceuticals, Inc. (SANDUPHQ) FAQ
What is the stock price today?
The current price is ₹39.48.
On which exchange is it traded?
Sandu Pharmaceuticals, Inc. is listed on MSE.
What is its stock symbol?
The ticker symbol is SANDUPHQ.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1.6%.
What is its market cap?
As of today, the market cap is 328.47M.
Has Sandu Pharmaceuticals, Inc. ever had a stock split?
No, there has never been a stock split.
Sandu Pharmaceuticals, Inc. Profile
| Pharmaceuticals Industry | Healthcare Sector | - CEO | MSE Exchange | INE751D01014 ISIN |
| India Country | 303 Employees | 18 Sep 2025 Last Dividend | - Last Split | - IPO Date |
Sandu Pharmaceuticals, Inc. is a health-care-focused company that specializes in the development, production, and distribution of pharmaceutical products. Its primary function is to create medications that improve patient health and wellbeing across a range of medical conditions. The company is involved in research and development, bringing innovative solutions to pressing healthcare challenges.
Noteworthy within the pharmaceutical sector, Sandu Pharmaceuticals covers various therapeutic areas, offering treatments that target chronic diseases, acute medical conditions, and rare disorders. The company operates manufacturing facilities that adhere to stringent regulatory standards, ensuring the safety and efficacy of its drug formulations.
In the financial market, Sandu Pharmaceuticals plays a vital role as a contributing entity in the biopharmaceutical industry. The firm’s activities have significant implications for healthcare access and affordability, impacting both local and global communities. By advancing medical technology and treatments, Sandu Pharmaceuticals supports the broader healthcare infrastructure, creating demand for its pharmaceutical offerings and influencing the sector's economic dynamics.
Contact Information
Address: P.B. No. 17201
Phone: 91 22 2528 4402
Website: https://sandu.in
